Clinical features and visual outcomes of Japanese patients with scleritis

British Journal of Ophthalmology

Volumn 94, Issue 11, 2010, Pages 1459-1463

  Keino, H ^a   Watanabe, T ^a   Taki, W ^a   Nakashima, C ^a   Okada, Annabelle A ^a  

^a KYORIN UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CHILD; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; HYPERGLYCEMIA; INTRAOCULAR PRESSURE; IRIDOCYCLITIS; JAPANESE; MAJOR CLINICAL STUDY; MALE; OSTEOPOROSIS; PRIORITY JOURNAL; SCLERITIS; TUBERCULOSIS; JAPAN; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; RETROSPECTIVE STUDY; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; AGED; AGED, 80 AND OVER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CHILD; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; JAPAN; MIDDLE AGED; RETROSPECTIVE STUDIES; SCLERITIS; TREATMENT OUTCOME; VISUAL ACUITY; YOUNG ADULT;

EID: 78149474867     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2009.171744     Document Type: Article

References (22)

1. McCluskey PJ, Wakefield D. Scleritis and episcleritis. In: Pepose JS, Holland GN, Wilhelmus KR, eds. Ocular infection and immunity. St. Louis: Mosby, 1996:642-7.
2. Okhravi N, Odufuwa B, McCluskey P, et al. Scleritis. Surv Ophthalmol 2005;50:351-63.
3. Watson PG, Hayreh SS. Scleritis and episcleritis. Br J Ophthalmol 1976;60:163-91.
4. Sainz de la Maza M, Jabbur NS, Foster CS. Severity of scleritis and episcleritis. Ophthalmology 1994;101:389-96.
5. McGavin DDM, Williamson J, Forrester JV, et al. Episcleritis and scleritis. A study of their clinical manifestation and association with rheumatoid arthritis. Br J Ophthalmol 1976;60:192-226.
6. Akpek EK, Throne EJ, Qazi FA, et al. Evaluation of patients with scleritis for systemic disease. Ophthalmology 2004;111:501-6.
7. Smith JR, Mackensen F, Rosenbaum JT. Therapy insight: scleritis and its relationship to systemic autoimmune disease. Nat Clin Practice 2007;3:219-26. (Pubitemid 46860406)
8. Wakefield D, McCluskey P. Cyclosporin therapy for severe scleritis. Br J Ophthalmol 1989;73:743-6.
9. Shah SS, Lowder CY, Schmitt MA, et al. Low-dose methotrexate therapy for ocular inflammatory disease. Ophthalmology 1992;99:1419-23.
10. Jabs DA, Mudun A, Dunn JP, et al. Episcleritis and Scleritis: Clinical features and treatment results. Am J Ophthalmol 2000;130:469-76.
11. Throne EJ, Jabs DA, Qaiz FA, et al. Mycophenolate mofetil therapy for inflammatory eye disease. Ophthalmology 2005;112:1472-7.
12. Nakajima N, Hayasaka S. Clinical features of episcleritis and scleritis in some Japanese patients. Ophthalmologica 1995;209:256-9.
13. Anshu A, Chee SP. Posterior scleritis and its association with HLA B27 haplotype. Ophthalmologica 2007;221:275-8. (Pubitemid 46956807)
14. McCluskey PJ, Watson PG, Lightman S, et al. Posterior scleritis. Clinical features, systemic associations, and outcome in a large series of patients. Ophthalmology 1999;106:2380-6.
15. Morimura Y, Okada AA, Kawahara S, et al. Tuberculin skin test in uveitis patients and treatment of presumed intraocular tuberculosis in Japan. Ophthalmology 2002;109:851-7.
16. Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomeclature for reportingclinical data: results of the First International Workshop. Am J Ophthalmol 2005;140:509-16.
17. World Health Organization/CDS/TB/2003.313. Treatment of tuberculosis: guidelines for national programmes. 3rd edn. Revision approved by STAG, 2004 (accessed 14 Aug 2009).
18. Araki K, Nakagawa Y, Tada R, et al. Clinical features of 75 cases of scleritis during the past 11 years. Jpn J Clin Ophthalmol 1987;41:1075-8.
19. Kurosaka H, Muraki Y, Suzuki S. Evaluation of 106 cases of scleritis in our hospital. Folia Ophthalmol Jpn 1994;45:797-803.
20. Jachens AW, Chu AD. Retrospective review of methotrexate therapy in the treatment of chronic, noninfectious, nonnecrotizing scleritis. Am J Ophthalmol 2008;145:487-92.
21. Tabbara KF. Tuberculosis. Curr Opin Ophthalmol 2007;18:493-501.
22. Mori T, Sakatani M, Yamagishi F, et al. Specific detection of tuberculosis infection. Am J Respir Crit Care Med 2004;170:59-64.